Multimodal self-supervised deep learning for precision cancer medicine

Description of the granted funding

Precision cancer medicine aims to obtain treatment-impacting information on individual cancer cases by performing in-depth cancer profiling. Profiling often includes tissue imaging and, more recently, sequencing of cancer genomes. Machine learning methods such as ChatGPT have been shown to be capable of solving a wide range of problems expressed in natural language or as images. Here, we seek to employ similar machine learning approaches in precision cancer medicine to answer questions such as what is the molecular subtype and suitable treatments for particular cancer, or whether a cancer may be aggressive or indolent. To do this, we will develop machine learning models that do not require guidance by experts, but instead learn to automatically recognize similarities and differences between cancers based on histological images and genomics data. These models can then be used to create software tools to assist clinicians to better diagnose and treat patients.
Show more

Starting year

2025

End year

2029

Granted funding

Esa Pitkänen Orcid -palvelun logo
600 000 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Decision maker

Scientific Council for Natural Sciences and Engineering
12.06.2025

Other information

Funding decision number

372081

Fields of science

Biomedicine

Research fields

Systeemibiologia, bioinformatiikka

Identified topics

cancer